BRIEF published on 03/25/2024 at 15:27, 1 year 3 months ago Vanguard Group augmente sa participation dans Ageas SA/NV Actionnariat Opérations Boursières Groupe D'avant-garde Ageas SA/NV Investissements Financiers
BRIEF published on 03/25/2024 at 15:27, 1 year 3 months ago Vanguard Group Increases Stake in Ageas SA/NV Vanguard Group Shareholding Stock Transactions Ageas SA/NV Financial Investments
PRESS RELEASE published on 03/25/2024 at 15:22, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 22 March 2024. Additional disclosures related to Direct Line Insurance Group plc and recent securities transactions are provided in Form 8.3 Securities Transactions The Vanguard Group, Inc. Disclosure Ageas SA/NV
BRIEF published on 03/22/2024 at 15:26, 1 year 3 months ago Vanguard annonce une participation dans Ageas SA/NV Marchés Financiers Groupe D'avant-garde Ageas SA/NV Divulgation Des Titres Investissement Dans Le Secteur Des Assurances
BRIEF published on 03/22/2024 at 15:26, 1 year 3 months ago Vanguard Reports Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Insurance Sector Investment
PRESS RELEASE published on 03/22/2024 at 15:21, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.46% ownership in Ageas SA/NV as of 21 March 2024. Also making disclosures related to Direct Line Insurance Group plc Disclosure Vanguard Group Inc. Ownership Ageas SA/NV Direct Line Insurance Group Plc
BRIEF published on 03/21/2024 at 15:11, 1 year 3 months ago Vanguard Group dévoile sa participation dans Ageas SA/NV Marchés Financiers Groupe D'avant-garde Ageas SA/NV Divulgation Des Titres Détention D'investissement
BRIEF published on 03/21/2024 at 15:11, 1 year 3 months ago Vanguard Group Discloses Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Investment Holding
PRESS RELEASE published on 03/21/2024 at 15:06, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 20 March 2024. Details include securities holdings and recent transactions Financial Transactions The Vanguard Group, Inc. Form 8.3 Disclosure Ageas SA/NV Securities Holdings
BRIEF published on 03/20/2024 at 14:27, 1 year 3 months ago Vanguard Increases Stake in Ageas SA/NV Vanguard Group Financial Markets Share Ownership Ageas SA/NV Insurance Sector
Published on 07/15/2025 at 12:30, 33 minutes ago FireFox Launches a $5.0 Million Financing With A Concurrent Share Consolidation
Published on 07/15/2025 at 12:00, 1 hour 3 minutes ago Primary Hydrogen Launches Phase 2 Hydrogen Sampling at Crooked Amphibolite, Coquihalla, And Cogburn Projects In British Columbia
Published on 07/15/2025 at 09:05, 3 hours 58 minutes ago Nano One Selected to Join U.S. ALTA and Strengthen North American Battery Supply Chain
Published on 07/15/2025 at 09:01, 4 hours 2 minutes ago Star Copper Provides Site Visit Update of Ongoing Drill Campaign in British Columbia's Golden Triangle
Published on 07/15/2025 at 07:10, 5 hours 53 minutes ago SAINT BELLA Debuts in the U.S., Setting a New Standard for Postpartum Care
Published on 07/15/2025 at 12:49, 14 minutes ago EQS-Adhoc: CERDIOS SE: Results of the Annual General Meeting
Published on 07/15/2025 at 12:42, 21 minutes ago EQS-Adhoc: Limes Schlosskliniken AG: Capital increase at LIMES Schlosskliniken AG to service stock options
Published on 07/15/2025 at 12:12, 51 minutes ago Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology.
Published on 07/15/2025 at 11:41, 1 hour 22 minutes ago EQS-Adhoc: Redcare Pharmacy’s CardLink solution extended by gematik.
Published on 07/15/2025 at 07:00, 6 hours 3 minutes ago Biophytis s’associe à Lynx Analytics dans le domaine de l’IA pour accélérer la découverte de médicaments contre la sarcopénie
Published on 07/15/2025 at 07:00, 6 hours 3 minutes ago Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for Sarcopenia
